FDC Ltd., a leading Indian pharmaceutical company, announced its financial results for the fourth quarter (Q4FY24) and the full fiscal year 2024 (FY24).
Q4FY24 Financial Highlights:
Revenue from Operations: ₹495.21 crore (YoY growth of 11.39%)
EBITDA: ₹117.46 crore (YoY growth of 28.31%)
EBITDA Margin: 23.72%
Profit After Tax (PAT): ₹7 6.77 crore (YoY growth of 35.43%)
EPS: ₹4.63
FY24 Financial Highlights:
Revenue from Operations: ₹1,777.03 crore (YoY growth of 22.57%)
EBITDA: ₹421.05 crore (YoY growth of 58.85%)
EBITDA Margin: 23.70%
Profit After Tax (PAT): ₹277.88 crore (YoY growth of 65.78%)
EPS: ₹16.75
Key Highlights:
Strong Growth: FDC Ltd. witnessed robust growth in revenue and profitability in both Q4FY24 and FY24.
Improved Margins: The company's EBITDA and PAT margins improved significantly, indicating efficient cost management and operational efficiency.
New Product Launches: FDC launched several new products during the year, contributing to the revenue growth.
Geographical Expansion: The company expanded its presence in new geographies, further boosting its sales.
Management Commentary:
The management expressed satisfaction with the company's strong performance in FY24 and attributed it to the successful execution of its strategic initiatives. They highlighted the focus on new product launches, geographical expansion, and operational efficiency as key drivers of growth.
For further information and analysis, you can refer to the following resources:
FDC Limited Official Website: https://www.fdcindia.com/
Comments